Atrial fibrillation: The remodelling phenomenon

European Heart Journal, Supplement

Volumn 5, Issue H, 2003, Pages

  Botto, Giovanni Luca ^a   Luzi, M ^a   Sagone, A ^a  

^a SANT ANNA HOSPITAL   (Italy)

Author keywords

Antiarrhythmic drugs; Atrial fibrillation; Atrial remodelling; Cardioversion of atrial fibrillation; Electrophysiological remodelling

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL L TYPE; ION CHANNEL; VERAPAMIL;

ACTION POTENTIAL; CARDIOVERSION; CONFERENCE PAPER; ELECTROPHYSIOLOGY; GOAT; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD;

EID: 0141891856     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(03)90017-4     Document Type: Conference Paper

References (31)

1. Kannel WB, Abbott RD, Savage DD, et al. Epidemiological features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
2. Kopecky SL, Gersh BJ, McGoon MD, et al. The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 1987;317:669-74.
3. Reisinger J, Gatterer E, Heinze G, et al. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. Am J Cardiol 1998;81:1450-4.
4. Botto GL, Politi A, Bonini W, et al. External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements. Heart 1999;82:726-30.
5. Tieleman RG, Van Gelder IC, Crijns HJ, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31:167-73.
6. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronicalty instrumented goats. Circulation 1995;92:1954-68.
7. Allessie MA. Atrial electrophysiologic remodeling: another vicious circle? J Cardiovasc Electrophysiol 1998;9:1378-93.
8. Janse MJ, van der Steen AB, van Dam RT. Refractory period of the dog's ventricular myocardium following sudden changes in frequency. Circ Res 1969;24:251-62.
9. Morillo CA, Klein GJ, Jones DL, et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial-fibrillation. Circulation 1995;91:1588-95.
10. Wang Z, Page P, Nattel S. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation. Circ Res 1992;71:271-87.
11. Attuel P, Childers R, Cauchemez B, et al. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. Int J Cardiol 1982;2:179-97.
12. Franz MR, Karasik PL, Li C, et al. Electrical remodelling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997;30:1785-92.
13. Yu WC, Le SH, Tai CT, et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res 1999;42:470-6.
14. Pandozi C, Bianconi L, Villani M, et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 1998;98:2860-5.
15. Pandozi C, Santini M. Update on atrial remodelling owing to rate; does atrial fibrillation always 'beget' atrial fibrillation? Eur Heart J 2001;22:541-53.
16. Yue L, Melnyk P, Gaspo R, et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999;84:776-84.
17. Van Wagoner DR, Pond AL, Lamorgese M, et al. Atrial L-type Ca2+ currents and atrial fibrillation. Circ Res 1999;85:428-36.
18. Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999;42:298-308.
19. Tieleman RG, Crijns HJ. The 'second factor' of tachycardia-induced atrial remodeling. Cardiovasc Res 2000;46:364-6.
20. Langberg JJ. 'Atrial fibrillopathy': is atrial fibrillation realty self-perpetuating? J Cardiovasc Eiectrophysiol 1999;10:1109-11.
21. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-74.
22. Tieleman RG, De Langen C, Van Gelder IC, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-53.
23. Tieleman RG, Blaauw Y, Van Gelder IC, et al. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation 1999;100:1836-42.
24. De Simone A, Stabile G, Vitale DF, et al. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. J Am Coll Cardiol 1999;34:810-14.
25. Crijns HJ, van Noord T, van Gelder IC. Recurrence of atrial fibrillation and the need for new definitions. Eur Heart J 2001;22:1769-71.
26. Botto GL, Belotti G, Cirò A, et al. Verapamil pre-treatment before electrical cardioversion of persistent atrial fibrillation: the VERAF Study [abstract]. Eur Heart J 2001;22:329.
27. Botto GL, Belotti G, Piti A, et al. Verapami effect on atrial fibrillation. Action on trigger or on substrate? [abstract]. Eur Heart J 2001;22:328.
28. Van Noord T, Van Gelder IC, Tieleman RG, et al. VERDICT: the Verapamil versus Digoxin Cardioversion Trial: a randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2001;12:766-9.
29. Nakashima H, Kumagai K, Urata H, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101:2612-17.
30. Lòpez B, Querejeta R, Varo N, et al. Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation 2001;104:286-91.
31. Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-6.